secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lifeloc Technologies, Inc (LCTC)
CIK:        0001493137
Form:       8-K
Filed at:   2025-08-11T23:59:59+00:00
Accession:  0001079973-25-001238
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lifeloc Q2 2025 net loss $(394k), revenue -7% YoY; SpinDx beta testing begins, launch expected early 2026
--------------------------------------------------------------------------------

- Net revenue $2.219M, down 7% YoY; net loss $(394k) ($0.14 loss per share) vs $(298k) loss in Q2 2024.
- Gross margin stable at 41.7%; R&D spend $623k primarily on SpinDx drug testing platform.
- SpinDx beta testing underway for delta-9-THC detection; commercial launch targeted for early 2026.
- Company began trading on OTCID tier of OTC Markets effective July 1, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1493137/000107997325001238/0001079973-25-001238-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1493137/000107997325001238/lctc_8k.htm
  HTML page:      https://secwatch.observer/filing/0001079973-25-001238

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer